Identification of the Oncogenic Role of MSH2 in the Stemness and Progression of Glioma Through Regulating Wnt Signaling Pathway
ABSTRACT Background Glioma is one of the most aggressive brain tumors, and its progression is often associated with stemness maintenance and therapy resistance. The role of MSH2 in glioma remains largely unclear. Methods We analyzed public datasets and clinical samples to assess MSH2 expression and...
Saved in:
| Main Authors: | Jun Liu, Jiayu Chen, Lianglei Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70993 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity
by: Ning He, et al.
Published: (2025-07-01) -
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression
by: Kirsten Brooksbank, et al.
Published: (2025-09-01) -
Systematic analysis identifies TRIM22 as an oncogenic and immunological biomarker in glioma
by: Yuanyuan Hu, et al.
Published: (2025-07-01) -
MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome or the FXN locus in Friedreich’s ataxia
by: Jessalyn Grant-Bier, et al.
Published: (2025-04-01) -
PEDIATRIC OPTIC PATHWAY GLIOMA: DIENCEPHALIC SYNDROME
by: A. F. Valiakhmetova, et al.
Published: (2021-03-01)